Symbol
CLDI on NYSE
Investment type
Equity / Common Stock, $0.0001 par value
Latest Disclosed Ownership
730K shares
Security Ownership
14.5%

Lincoln Alternative Strategies LLC ownership in Calidi Biotherapeutics, Inc. Common Stock, $0.0001 par value (CLDI)

2025-08-27 - Lincoln Alternative Strategies LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 730K shares of Calidi Biotherapeutics, Inc. Common Stock, $0.0001 par value (CLDI). This represents 14.5% percent ownership of the company.